Tag: brainstorm cell therapeutics

January 22, 2019

BrainStorm Granted Additional Patent for NurOwn in Israel

BrainStorm Cell Therapeutics (NASDAQ:BCLI), a leader in developing innovative autologous cellular therapies for debilitating neurodegenerative diseases, today announced that the...
January 18, 2019

This is the Year for NurOwn’s Stem Cell Phase 3 ALS Development

Brainstorm Cell Therapeutics' management team discusses an ongoing ALS Phase 3 clinical trial, the company's technology and more.
January 7, 2019

Notes from the Floor: Biotech Showcase, Day 1

The Biotech Showcase takes place in San Francisco from January 7 to 9. Here's what went on during the conference...
December 17, 2018

FDA Accepts BrainStorm’s NurOwn IND Application for Progressive Multiple Sclerosis

BrainStorm Cell Therapeutics (NASDAQ:BCLI), a leading developer of innovative autologous adult stem cell therapeutics for debilitating neurodegenerative diseases, announced that the...
August 23, 2018

BrainStorm Cell Therapeutics Announces Positive Interim Safety Analysis

On Thursday, BrainStorm Cell Therapeutics announced that its Phase 3 trial for NurOwn in patients with ALS will be able...
May 3, 2017

4 Top NASDAQ Biotech Stocks 100 Days in Under Trump's Presidency

Even though a Trump presidency hasn't been favorable to the biotech sector, at least four stocks have performed well the...
March 6, 2017

BrainStorm Cell Therapeutics appoints new Chief Operating Officer and Chief Medical Officer

BrainStorm Cell Therapeutics (NASDAQ:BCLI) announced the appointment of Dr. Ralph Z. Kern as its new Chief Operating Officer and Chief...